Navigation Links
How to Achieve Alignment and Optimal Clinical Trial Supply Forecasting With a Single Source of Truth, Upcoming Webinar Hosted by Xtalks

A clinical trial usually involves many different parties, who are not always used to communicating with each other: study managers, principal investigators, supply chain managers, manufacturers, IRT, CRAs and so on. Lack of communication can cause misunderstandings if a party is not informed of the latest data, potentially leading to patient risk.

By having a single source of truth, each collaborator can transparently access the latest clinical forecasts as well as up-to-date data including enrollment and dropout rate, titrations probabilities, future productions, etc. The reliability of this information is a must as it plays a fundamental role in the clinical supply strategy, as well as planning including distribution, packaging, manufacturing and sampling.

Join Head of Solutions Adoption, Life Sciences at N-SIDE, Amaury Jeandrain and N-SIDE Consultant, Pauline Deplasse in a live session on Tuesday, November 19, 2019 at 10am EST (3pm GMT/UK) to learn about the benefits of having a single source of truth when managing clinical operations.

If everyone agrees on this single source of truth, the resulting forecasts can legitimately be used across the organization for resource planning activities, decision-making, vendor management, etc. through strategic visualization dashboards.

When changes occur, such as faster enrollment, batch losses, shipping delays, new countries in the trial, real-time monitoring and updating clinical trial supply forecasts, using real-time data allows the single source of truth to stay current. This enables everyone across the organization to adapt their planning in order to mitigate the unexpected risk, ensuring patients will receive their medication on time while minimizing the costs.

The featured speakers will discuss how to get clinical trial stakeholders on the same page, using a single source of truth for patient behavior, demand forecast, production/distribution plans and inventory management.

For more information or to register for this event, visit How to Achieve Alignment and Optimal Clinical Trial Supply Forecasting With a Single Source of Truth.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit
For information about hosting a webinar, visit

Candice Tang
Tel: +1 (416) 977-6555 ext 400

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Ritchie Shoemaker Pleased to Announce Second Physician Achieves Shoemaker Protocol Certification for Treating Chronic Inflammatory Response Syndrome
2. Heptares Achieves All Research Milestones and Receives Milestone Payment From GPCR Drug Discovery Agreement With Takeda
3. Pioneering Researchers Recognized for Scientific Achievements in Gene and Cell Therapy
4. Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis
5. Ohr Pharmaceutical Achieves 50% Enrollment Milestone in Squalamine Eye Drop Phase II Clinical Trial
6. AMS Co-Founder John Hauser Receives Lifetime Achievement Award
7. PTC Therapeutics Announces Achievement Of Major Milestone In SMA Collaboration
8. Pathogenica Achieves CE Marking for HAI BioDetection Kit
9. Medflow EHR Achieves ONC-ACB Certification by Drummond Group
10. Circassias Short-Course House Dust Mite Allergy Treatment Achieves Significant Long-Term Symptom Reduction
11. Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDL
Post Your Comments:
(Date:1/10/2020)... ... January 09, 2020 , ... ... services, today announced the acquisition of Cunesoft, a move that expands the company’s ... objectives of life sciences companies. , Based in Munich, Germany, Cunesoft provides intelligent ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... can achieve specific properties for use in harsh environments inside or outside of ... up to three metals or alloys to achieve specific properties such as corrosion-resistance, ...
(Date:1/7/2020)... , ... January 07, 2020 , ... ... products and services, today announced the launch of its VivopureX™ recombinant mouse antibodies ... clones, many originally obtained from rats or hamsters, which Absolute Antibody has engineered ...
(Date:1/7/2020)... ... January 06, 2020 , ... EconoFact, a non-profit ... Fletcher School at Tufts University, is pleased to announce that it was awarded ... administered by Tufts University, and will help to expand the scope, exposure and ...
Breaking Biology Technology:
(Date:12/4/2019)... ... December 03, 2019 , ... Genedata, the ... Agenus , a clinical-stage immuno-oncology company developing therapies to fight cancer, has chosen ... Agenus will use the platform to support immunotherapy and vaccine pipeline programs across ...
(Date:12/2/2019)... ... December 01, 2019 , ... Each year The ... to hit the life-science landscape. For more than a decade, our expert panels ... and facilitating biological discovery. This year’s crop of entries to The Scientist’s Top ...
(Date:11/27/2019)... ... 2019 , ... The MyOnyx rehab solution by ... that measure and display muscle activity in real time. This information helps the ... Both patient and therapist can see when exercises are performed correctly and efficiently. ...
Breaking Biology News(10 mins):